This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Valo Therapeutics Oy. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Petri Priha: Innovator in Cancer Therapy
Introduction
Petri Priha is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of cancer therapy through his innovative work. His research focuses on utilizing modified oncolytic adenoviruses to develop effective treatments for cancer.
Latest Patents
Petri Priha holds 1 patent related to his groundbreaking invention in cancer therapy. The patent concerns a modified oncolytic adenovirus, a pharmaceutical composition comprising the same, and a method of treating cancer using this technology. This invention has the potential to revolutionize cancer treatment by targeting cancer cells more effectively.
Career Highlights
Petri Priha is currently associated with Valo Therapeutics Oy, a company dedicated to advancing cancer therapies. His work at Valo Therapeutics Oy has positioned him as a key player in the development of innovative cancer treatments. His expertise and dedication to research have garnered attention in the scientific community.
Collaborations
Petri has collaborated with talented individuals such as Tuuli Ranki and Sari Pesonen. These collaborations have enriched his research and contributed to the advancement of cancer therapy.
Conclusion
In summary, Petri Priha is an influential inventor whose work in cancer therapy is paving the way for new treatment options. His innovative approach and dedication to research are commendable and hold promise for the future of cancer treatment.